share_log

康希諾生物:海外監管公告

CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Hong Kong Stock Exchange ·  Apr 29 10:07
Summary by Moomoo AI
康希諾生物於2024年4月29日召開第三屆監事會第三次會議,會議以現場及通訊方式進行,並符合相關法律法規及公司章程規定。會議審議通過了三項議案,包括2024年第一季度報告、簽署產品轉讓與技術許可協議暨關聯交易,以及公司未彌補虧損達實收股本總額三分之一的議案。所有議案均以3票同意、0票反對、0票棄權的結果通過。其中,關於公司未彌補虧損的議案尚需提交股東大會審議。會議決議的具體內容已於同日在上海證券交易所網站公布。
康希諾生物於2024年4月29日召開第三屆監事會第三次會議,會議以現場及通訊方式進行,並符合相關法律法規及公司章程規定。會議審議通過了三項議案,包括2024年第一季度報告、簽署產品轉讓與技術許可協議暨關聯交易,以及公司未彌補虧損達實收股本總額三分之一的議案。所有議案均以3票同意、0票反對、0票棄權的結果通過。其中,關於公司未彌補虧損的議案尚需提交股東大會審議。會議決議的具體內容已於同日在上海證券交易所網站公布。
The third meeting of the Third Board of Supervisors was held on 29 April 2024 on 29 April 2024. The meetings were conducted on-site and in accordance with the relevant laws and regulations and the articles of association. THE MEETING APPROVED THREE MOTIONS, INCLUDING THE 2024 FIRST QUARTER REPORT, THE SIGNING OF THE PRODUCT TRANSFER AND TECHNICAL LICENSING AGREEMENT, AND THE ASSOCIATED TRANSACTION, AND THE RESOLUTION OF ONE-THIRD OF THE TOTAL SHARE CAPITAL OF THE COMPANY'S UNCOMPENSATED LOSSES. All motions passed with 3 votes in favour, 0 against and 0 abstentions. Among them, the resolution of the Company's outstanding losses is still subject to submission to the General Meeting. The details of the meeting resolution were published on the Shanghai Stock Exchange website on the same day.
The third meeting of the Third Board of Supervisors was held on 29 April 2024 on 29 April 2024. The meetings were conducted on-site and in accordance with the relevant laws and regulations and the articles of association. THE MEETING APPROVED THREE MOTIONS, INCLUDING THE 2024 FIRST QUARTER REPORT, THE SIGNING OF THE PRODUCT TRANSFER AND TECHNICAL LICENSING AGREEMENT, AND THE ASSOCIATED TRANSACTION, AND THE RESOLUTION OF ONE-THIRD OF THE TOTAL SHARE CAPITAL OF THE COMPANY'S UNCOMPENSATED LOSSES. All motions passed with 3 votes in favour, 0 against and 0 abstentions. Among them, the resolution of the Company's outstanding losses is still subject to submission to the General Meeting. The details of the meeting resolution were published on the Shanghai Stock Exchange website on the same day.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more